| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e308161d9103bf72bfc0b94ed43470df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_685fb0bd08eb154d289e87d465b6fc48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c0c1c75ae6c61905ab0a7aa91323b288
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d2eee92d6c2cdf9566172d59dd815434 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
| filingDate |
2007-07-03^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e3e238ecc425e928f563b443bb171df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7c77af9840c6781bad83b19782f1d2f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_302cfa68cac5df34a4646a15ab0b1660 |
| publicationDate |
2008-01-10^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2008003511-A1 |
| titleOfInvention |
Use of aminothiazole derivative compounds, pharmaceutical compositions thereof, in the treatment of diseases characterized by abnormal repression of gene transcription, particularly huntington's disease |
| abstract |
The present invention relates to the use of aminothiazole compounds and pharmaceutical compositions thereof in the medical practice. More specifically, the instant invention relates to the use of aminothiazole derivatives and pharmaceutical compositions thereof in the treatment and/or prophylaxis and/or prevention of diseases and/or pathological conditions characterized by the abnormal repression of gene transcription and/or by neurodegeneration, particularly the Huntington's disease. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8513276-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8859543-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8859583-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8796244-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10604523-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8859582-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8716282-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8481531-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8722687-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8188272-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8076354-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8071614-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7892830-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020112845-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9669035-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9550784-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8895745-B2 |
| priorityDate |
2006-07-05^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |